Ultragenyx Pharmaceutical | RARE - Capitalización De Mercado





Capitalización De Mercado Cambio Fecha
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
Agios Pharmaceuticals USD 1.53B 57M 2026-04
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
BioMarin Pharmaceutical USD 11.42B 1.02B 2025-12
Esperion Therapeutics USD 885M 351M 2025-12
Immunic USD 898M 834M 2026-04
Insmed USD 37.12B 6.68B 2025-12
Ionis Pharmaceuticals USD 10.55B 1.91B 2026-04
Karyopharm Therapeutics USD 652M 517M 2026-04
Kyowa Hakko Kirin JPY 1.33T 120.11B 2025-12
MacroGenics USD 102M 4M 2025-12
Neurocrine Biosciences USD 14.14B 218M 2025-12
PTC Therapeutics USD 5.26B 844M 2026-04
Regeneron Pharmaceuticals USD 75.46B 6.22B 2026-04
Sarepta Therapeutics USD 2.26B 238M 2025-12
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12